Risk factors for early-onset group B streptococcal disease in neonates: A population-based case-control study

Carol Elaine Adair, Laura Kowalsky, Harvey Quon, Doreen Ma, Jayson Stoffman, Allison McGeer, Sheila Robertson, Melissa Mucenski, H. Dele Davies

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background: Infection with group B streptococcus (GBS) is a major cause of neonatal illness and death. We examined the antenatal and perinatal risk factors for early-onset GBS disease among neonates. Methods: We identified cases by population-based surveillance in all microbiology laboratories serving Alberta. A case was defined as any instance of a positive sterile-site GBS culture in an infant born between 1993 and 1997 who was either less than 7 days old or stillborn after 20 weeks' gestation. We randomly selected controls from a computer-compiled list of all hospital births, including stillbirths after 20 weeks' gestation, in Alberta during the study period. To increase power, we chose 5 or 6 control infants born in the same year as each case infant. We reviewed hospital, prenatal clinic and physician health records and, between 1997 and 1999, conducted maternal interviews by telephone. Results: There were no differences between the 90 cases and 489 controls in sociodemographic variables or in many reproductive and behavioural variables. Case infants were more likely than control infants to be of low birth weight (odds ratio [OR] 3.60, 95% confidence interval [CI] 1.68-7.65), to have been delivered preterm (OR 3.89, 95% CI 2.08-7.27), or to have a mother with amnionitis (OR 15.03, 95% CI 5.58-41.89), intrapartum fever (OR 4.65, 95% CI 2.48-8.69) or premature rupture of the membranes (OR 2.39, 95% CI 1.38-4.14). After adjustment for potential confounders, intrauterine fetal monitoring was associated with a more than 2-fold increase in the risk of neonatal GBS disease (OR 2.24, 95% CI 1.22-4.13). Interpretation: Intrauterine fetal monitoring should be added to the list of risk factors in risk-based screening. Since many of the cases had no identifiable maternal risk factors, universal screening for GBS may be appropriate.

Original languageEnglish (US)
Pages (from-to)198-203
Number of pages6
JournalCMAJ
Volume169
Issue number3
StatePublished - Aug 5 2003

Fingerprint

Streptococcus agalactiae
Case-Control Studies
Odds Ratio
Newborn Infant
Confidence Intervals
Population
Fetal Monitoring
Alberta
Mothers
Population Surveillance
Chorioamnionitis
Pregnancy
Stillbirth
Low Birth Weight Infant
Microbiology
Rupture
Fever
Parturition
Interviews
Physicians

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Adair, C. E., Kowalsky, L., Quon, H., Ma, D., Stoffman, J., McGeer, A., ... Davies, H. D. (2003). Risk factors for early-onset group B streptococcal disease in neonates: A population-based case-control study. CMAJ, 169(3), 198-203.

Risk factors for early-onset group B streptococcal disease in neonates : A population-based case-control study. / Adair, Carol Elaine; Kowalsky, Laura; Quon, Harvey; Ma, Doreen; Stoffman, Jayson; McGeer, Allison; Robertson, Sheila; Mucenski, Melissa; Davies, H. Dele.

In: CMAJ, Vol. 169, No. 3, 05.08.2003, p. 198-203.

Research output: Contribution to journalArticle

Adair, CE, Kowalsky, L, Quon, H, Ma, D, Stoffman, J, McGeer, A, Robertson, S, Mucenski, M & Davies, HD 2003, 'Risk factors for early-onset group B streptococcal disease in neonates: A population-based case-control study', CMAJ, vol. 169, no. 3, pp. 198-203.
Adair CE, Kowalsky L, Quon H, Ma D, Stoffman J, McGeer A et al. Risk factors for early-onset group B streptococcal disease in neonates: A population-based case-control study. CMAJ. 2003 Aug 5;169(3):198-203.
Adair, Carol Elaine ; Kowalsky, Laura ; Quon, Harvey ; Ma, Doreen ; Stoffman, Jayson ; McGeer, Allison ; Robertson, Sheila ; Mucenski, Melissa ; Davies, H. Dele. / Risk factors for early-onset group B streptococcal disease in neonates : A population-based case-control study. In: CMAJ. 2003 ; Vol. 169, No. 3. pp. 198-203.
@article{53dcc8ed323c4b178f120a30b99a7825,
title = "Risk factors for early-onset group B streptococcal disease in neonates: A population-based case-control study",
abstract = "Background: Infection with group B streptococcus (GBS) is a major cause of neonatal illness and death. We examined the antenatal and perinatal risk factors for early-onset GBS disease among neonates. Methods: We identified cases by population-based surveillance in all microbiology laboratories serving Alberta. A case was defined as any instance of a positive sterile-site GBS culture in an infant born between 1993 and 1997 who was either less than 7 days old or stillborn after 20 weeks' gestation. We randomly selected controls from a computer-compiled list of all hospital births, including stillbirths after 20 weeks' gestation, in Alberta during the study period. To increase power, we chose 5 or 6 control infants born in the same year as each case infant. We reviewed hospital, prenatal clinic and physician health records and, between 1997 and 1999, conducted maternal interviews by telephone. Results: There were no differences between the 90 cases and 489 controls in sociodemographic variables or in many reproductive and behavioural variables. Case infants were more likely than control infants to be of low birth weight (odds ratio [OR] 3.60, 95{\%} confidence interval [CI] 1.68-7.65), to have been delivered preterm (OR 3.89, 95{\%} CI 2.08-7.27), or to have a mother with amnionitis (OR 15.03, 95{\%} CI 5.58-41.89), intrapartum fever (OR 4.65, 95{\%} CI 2.48-8.69) or premature rupture of the membranes (OR 2.39, 95{\%} CI 1.38-4.14). After adjustment for potential confounders, intrauterine fetal monitoring was associated with a more than 2-fold increase in the risk of neonatal GBS disease (OR 2.24, 95{\%} CI 1.22-4.13). Interpretation: Intrauterine fetal monitoring should be added to the list of risk factors in risk-based screening. Since many of the cases had no identifiable maternal risk factors, universal screening for GBS may be appropriate.",
author = "Adair, {Carol Elaine} and Laura Kowalsky and Harvey Quon and Doreen Ma and Jayson Stoffman and Allison McGeer and Sheila Robertson and Melissa Mucenski and Davies, {H. Dele}",
year = "2003",
month = "8",
day = "5",
language = "English (US)",
volume = "169",
pages = "198--203",
journal = "Canadian Medical Association Journal",
issn = "0008-4409",
publisher = "Canadian Medical Association",
number = "3",

}

TY - JOUR

T1 - Risk factors for early-onset group B streptococcal disease in neonates

T2 - A population-based case-control study

AU - Adair, Carol Elaine

AU - Kowalsky, Laura

AU - Quon, Harvey

AU - Ma, Doreen

AU - Stoffman, Jayson

AU - McGeer, Allison

AU - Robertson, Sheila

AU - Mucenski, Melissa

AU - Davies, H. Dele

PY - 2003/8/5

Y1 - 2003/8/5

N2 - Background: Infection with group B streptococcus (GBS) is a major cause of neonatal illness and death. We examined the antenatal and perinatal risk factors for early-onset GBS disease among neonates. Methods: We identified cases by population-based surveillance in all microbiology laboratories serving Alberta. A case was defined as any instance of a positive sterile-site GBS culture in an infant born between 1993 and 1997 who was either less than 7 days old or stillborn after 20 weeks' gestation. We randomly selected controls from a computer-compiled list of all hospital births, including stillbirths after 20 weeks' gestation, in Alberta during the study period. To increase power, we chose 5 or 6 control infants born in the same year as each case infant. We reviewed hospital, prenatal clinic and physician health records and, between 1997 and 1999, conducted maternal interviews by telephone. Results: There were no differences between the 90 cases and 489 controls in sociodemographic variables or in many reproductive and behavioural variables. Case infants were more likely than control infants to be of low birth weight (odds ratio [OR] 3.60, 95% confidence interval [CI] 1.68-7.65), to have been delivered preterm (OR 3.89, 95% CI 2.08-7.27), or to have a mother with amnionitis (OR 15.03, 95% CI 5.58-41.89), intrapartum fever (OR 4.65, 95% CI 2.48-8.69) or premature rupture of the membranes (OR 2.39, 95% CI 1.38-4.14). After adjustment for potential confounders, intrauterine fetal monitoring was associated with a more than 2-fold increase in the risk of neonatal GBS disease (OR 2.24, 95% CI 1.22-4.13). Interpretation: Intrauterine fetal monitoring should be added to the list of risk factors in risk-based screening. Since many of the cases had no identifiable maternal risk factors, universal screening for GBS may be appropriate.

AB - Background: Infection with group B streptococcus (GBS) is a major cause of neonatal illness and death. We examined the antenatal and perinatal risk factors for early-onset GBS disease among neonates. Methods: We identified cases by population-based surveillance in all microbiology laboratories serving Alberta. A case was defined as any instance of a positive sterile-site GBS culture in an infant born between 1993 and 1997 who was either less than 7 days old or stillborn after 20 weeks' gestation. We randomly selected controls from a computer-compiled list of all hospital births, including stillbirths after 20 weeks' gestation, in Alberta during the study period. To increase power, we chose 5 or 6 control infants born in the same year as each case infant. We reviewed hospital, prenatal clinic and physician health records and, between 1997 and 1999, conducted maternal interviews by telephone. Results: There were no differences between the 90 cases and 489 controls in sociodemographic variables or in many reproductive and behavioural variables. Case infants were more likely than control infants to be of low birth weight (odds ratio [OR] 3.60, 95% confidence interval [CI] 1.68-7.65), to have been delivered preterm (OR 3.89, 95% CI 2.08-7.27), or to have a mother with amnionitis (OR 15.03, 95% CI 5.58-41.89), intrapartum fever (OR 4.65, 95% CI 2.48-8.69) or premature rupture of the membranes (OR 2.39, 95% CI 1.38-4.14). After adjustment for potential confounders, intrauterine fetal monitoring was associated with a more than 2-fold increase in the risk of neonatal GBS disease (OR 2.24, 95% CI 1.22-4.13). Interpretation: Intrauterine fetal monitoring should be added to the list of risk factors in risk-based screening. Since many of the cases had no identifiable maternal risk factors, universal screening for GBS may be appropriate.

UR - http://www.scopus.com/inward/record.url?scp=0042929698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042929698&partnerID=8YFLogxK

M3 - Article

C2 - 12900477

AN - SCOPUS:0042929698

VL - 169

SP - 198

EP - 203

JO - Canadian Medical Association Journal

JF - Canadian Medical Association Journal

SN - 0008-4409

IS - 3

ER -